Investors back new PLLA stent technology from Singapore

A new plastics technology developed in Singapore may emerge as an important player in the fast-developing market for bioresorbable coronary stents.

Amaranth Medical, a privately held medical device company based in Mountain View, CA, yesterday announced the closing of a $20 million financing led by a new investor from Singapore.

In 2005 Amaranth was spun out of Nanyang Technological University where two scientists invented a unique polylactide plastic. They say that the proprietary PLLA has the specific attributes needed for a stent, specifically a high degree of dimensional accuracy coupled with radial strength and flexibility. The properties are achieved through tailoring of crystalline and amorphous regions. Work on manufacturing technologies has taken place in Singapore....

Read more